Thomas Carroll, MD
Otolaryngology · Boston, MANPI 1699821280
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $39,243 of the $41,057 with a category attached, or 95.6%. 11 manufacturers reported payments, led by Merck at 36.4% of the total. Reporting peaked in 2023 at $12,016 and has fallen 98.8% since, to $142 in 2025. Among otolaryngology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $1109.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$15K
- Pentax Of America, Inc.$12K
- GSK$4K
- Ambu A/s$4K
- Sofregen Medical Inc.$3K
- Regeneron Healthcare Solutions, Inc.$3K
- plus $347 from 5 others
What the payments were for
- Consulting fees$39,24396%
- Travel & lodging$1,0313%
- Food & beverage$7842%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 14 | $14,933 |
| Pentax Of America, Inc. | 7 | $11,544 |
| GSK | 3 | $4,058 |
| Ambu A/s | 3 | $3,810 |
| Sofregen Medical Inc. | 1 | $3,325 |
| Regeneron Healthcare Solutions, Inc. | 3 | $3,040 |
| Freudenberg Medical, LLC | 1 | $147 |
| Olympus America Inc. | 2 | $62 |
| Steris Corporation | 1 | $61 |
| Covidien LP | 1 | $44 |
| Cook Medical LLC | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SilkVoice$10,875
- DUPIXENT$3,040
How this compares
$41,057 in reported general payments places this provider in the 95th percentile of 298 otolaryngology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 50 | $931 |
| Omeprazole | 14 | $289 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Boston
- Dennis PoeBoston$264K
- Peter WeberBoston$157K
- Kevin EmerickBoston$89K
- Benjamin BleierBoston$77K
- Gregory RandolphBoston$56K
- Daniel LeeBoston$52K
- Marika RussellBoston$50K
- Isaac WassermanBoston$50K
- Phillip HuyettBoston$48K
- David JungBoston$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.